PMV Pharmaceuticals, Inc. (PMVP) Misses Q3 EPS by 2c
Tweet
Share
E-mailGet Alerts PMVP Hot Sheet
Join SI Premium – FREE
PMV Pharmaceuticals, Inc. (NASDAQ: PMVP) reported Q3 EPS of ($0.37), $0.02 worse than the analyst estimate of ($0.35).
For earnings history and earnings-related data on PMV Pharmaceuticals, Inc. (PMVP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Roblox user data suggests bookings above guidance range
- L3Harris CEO steps down amid conduct review, shares drop
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
